In particular, while MS mutations seem to disrupt the ability to bind a target promoter, thus decreasing PHOX2B-mediated genes’ transcription ability [213,214], FS variants appear to be predisposed to NB by different mechanisms. The gene discussed is PHOX2B; the disease is neuroblastoma.